CELYAD ONCOLOGY Stock Over 34% Down In The Last 21 Sessions

(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) dropped by a staggering 34.41% in 21 sessions from €1.74 to €1.14 at 13:11 EST on Wednesday, following the last session’s upward trend. BEL 20 is dropping 0.91% to €3,865.79, following the last session’s downward trend. About CELYAD ONCOLOGY Celyad Oncology SA, a clinical-stage biopharmaceutical company,…

Read More